Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.vbshilpa.com | |
Market Cap | 2,107.98 Cr. | |
Enterprise Value(EV) | 2,853.00 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 2.45 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 100.37 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.44 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 207.01 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.19 | Calculated using Price: 246.30 |
Dividend Yield | 0.45 | Period Ending 2022-03 |
No. of Shares Subscribed | 8.68 Cr. | 86,801,898 Shares |
FaceValue | 1 | |
Company Profile | ||
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications. |
1 Day |
|
-1.18% |
1 Week |
|
-0.44% |
1 Month |
|
-11.88% |
3 Month |
|
-21.49% |
6 Month |
|
-40.86% |
1 Year |
|
-51.75% |
2 Year |
|
-42.61% |
5 Year |
|
-53.19% |
10 Year |
|
+168.62% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 20.98 | 15.40 | 17.66 | 12.85 | 9.93 | 9.59 | 12.23 | 10.41 | 3.67 | |
Return on Capital Employed (%) | 20.48 | 17.90 | 19.69 | 15.28 | 11.13 | 10.45 | 12.38 | 10.73 | 5.94 | |
Return on Assets (%) | 12.23 | 9.18 | 11.41 | 8.69 | 6.92 | 7.04 | 8.59 | 6.33 | 2.20 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 396 | 547 | 639 | 987 | 1,085 | 1,198 | 1,329 | 1,479 | 1,822 | 1,797 | |
Non Curr. Liab. | 105 | 154 | 67 | 251 | 153 | 167 | 257 | 561 | 453 | 339 | |
Curr. Liab. | 167 | 189 | 222 | 237 | 266 | 253 | 411 | 543 | 612 | 856 | |
Minority Int. | 10 | 14 | 2 | -3 | -5 | -8 | -8 | -11 | -11 | -9 | |
Equity & Liab. | 678 | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,983 | |
Non Curr. Assets | 444 | 577 | 577 | 742 | 827 | 1,065 | 1,365 | 1,730 | 1,988 | 2,074 | |
Curr. Assets | 234 | 328 | 354 | 730 | 672 | 545 | 624 | 819 | 887 | 909 | |
Misc. Exp. not W/O | 0 | 0 | |||||||||
Total Assets | 678 | 905 | 931 | 1,472 | 1,499 | 1,610 | 1,989 | 2,632 | 2,876 | 2,983 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 571 | 614 | 716 | 779 | 789 | 733 | 908 | 901 | 1,146 | 1,137 | |
Other Income | 9 | 7 | 11 | 29 | 33 | 16 | 22 | 40 | 21 | 23 | |
Total Income | 581 | 621 | 728 | 809 | 821 | 749 | 930 | 941 | 1,166 | 1,160 | |
Total Expenditure | -455 | -487 | -556 | -618 | -638 | -579 | -693 | -729 | -948 | -985 | |
PBIDT | 125 | 133 | 171 | 191 | 184 | 170 | 237 | 212 | 218 | 175 | |
Interest | -4 | -4 | -4 | -3 | -3 | -4 | -5 | -22 | -41 | -42 | |
Depreciation | -23 | -21 | -23 | -31 | -37 | -42 | -44 | -54 | -80 | -89 | |
Taxation | -20 | -35 | -36 | -42 | -34 | -26 | -33 | -49 | -42 | -16 | |
Exceptional Items | -3 | 0 | -2 | -5 | 20 | 61 | 9 | 0 | |||
PAT | 75 | 73 | 105 | 104 | 103 | 110 | 155 | 146 | 61 | 28 | |
Minority Interest | 1 | 1 | 4 | 3 | 2 | 3 | 2 | 2 | 0 | -2 | |
Share Associate | -5 | ||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 76 | 74 | 108 | 108 | 105 | 112 | 156 | 148 | 61 | 21 | |
Adjusted EPS | 10 | 10 | 14 | 13 | 13 | 14 | 19 | 18 | 7 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 44 | 70 | 69 | 129 | 37 | 45 | 147 | 124 | 47 | 105 | |
Cash Fr. Inv. | -95 | -49 | -195 | -109 | -262 | -9 | -196 | -290 | -404 | -286 | |
Cash Fr. Finan. | 66 | -28 | 136 | -20 | 313 | -61 | 10 | 176 | 436 | 83 | |
Net Change | 15 | -7 | 10 | 0 | 88 | -25 | -39 | 10 | 79 | -98 | |
Cash & Cash Eqvt | 17 | 9 | 18 | 6 | 100 | 74 | 34 | 44 | 123 | 25 |
Thu, 19 Jan 2023
Submission In Compliance With Regulation 76 Of The Securities And Exchange Board Of India (Depositories And Participants) Regulations 2018 For Quarter Ended 31 December 2022. Pursuant to Regulation 76 of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find herewith enclosed the Reconciliation of Share Capital Audit Report for Equity Shares dated 18 January 2023 for the Quarter ended 31 December 2022 issued by CS D.S. Rao Practicing Company Secretary Hyderabad. |
Thu, 19 Jan 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 19 2023 for Dharmavati Bhutada & Others |
Thu, 19 Jan 2023
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on January 19 2023 for Dharmavati Bhutada & Others |
Thu, 02 Feb 2023 |
|
|
|
|
|